ADCT ADC THERAPEUTICS SA SHS

Ownership history in Vantage Consulting Group Inc  ·  21 quarters on record

AI Ownership Summary

Vantage Consulting Group Inc reported ADC THERAPEUTICS SA SHS (ADCT) in 21 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 31.92% in 2025 Q2. The latest visible filing shows ADCT at 12.23% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ADCT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Vantage Consulting Group Inc's position in ADC THERAPEUTICS SA SHS, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ADCT was reported at 12.23% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
31.92% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Vantage Consulting Group Inc held ADCT — position size vs. price
% of Fund (quarterly)    ADCT price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 682,998 0% 12.23% $2.41B 2026-02-14 (Est.) $3.99
2025 Q3 UNCHANGED 682,998 0% 24.36% $2.73B 2025-11-06 $4.16
2025 Q2 REDUCED 682,998 -167,739 -19.7% 31.92% $1.83B 2025-08-12 $2.94
2025 Q1 UNCHANGED 850,737 0% 23.88% $1.20B 2025-05-09 $1.27
2024 Q4 UNCHANGED 850,737 0% 16.14% $1.69B 2025-02-12 $1.48
2024 Q3 UNCHANGED 850,737 0% 23.47% $2.68B 2024-11-14 $2.65
2024 Q2 UNCHANGED 850,737 0% 2.00% $2.7M 2024-08-14 $2.85
2024 Q1 UNCHANGED 850,737 0% 2.43% $3.8M 2024-05-15 $4.13
2023 Q4 UNCHANGED 850,737 0% 0.95% $1.4M 2024-02-14 $4.86
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Vantage Consulting Group Inc and ADCT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Vantage Consulting Group Inc reported owning ADCT?

Vantage Consulting Group Inc reported ADCT across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported ADCT position in Vantage Consulting Group Inc's portfolio?

The largest reported portfolio weight for ADCT was 31.92% in 2025 Q2.

What is the latest reported ADCT position on this page?

The most recent filing on this page is 2025 Q4, when Vantage Consulting Group Inc reported 682,998 shares, equal to 12.23% of portfolio, with an estimated market value of $2.41B.

What does the chart on this ADCT ownership page compare?

The chart compares Vantage Consulting Group Inc's quarterly ADCT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Vantage Consulting Group Inc Holdings